Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Mikhailidis
D P
DP
Ganotakis
E S
ES
Winder
A F
AF
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005340:Fibrinogen / Q000187:drug effects / Q000378:metabolism*; D005500:Follow-Up Studies; D018056:Hemorheology / Q000187:drug effects*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000188:drug therapy; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017035:Pravastatin / Q000627:therapeutic use*; D019821:Simvastatin
D000924:Anticholesteremic Agents; D005340:Fibrinogen; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin